Prestige Consumer Healthcare Inc. (NYSE:PBH) Receives Average Rating of “Moderate Buy” from Analysts

Prestige Consumer Healthcare Inc. (NYSE:PBH) has been assigned a consensus recommendation of “Moderate Buy” from the five analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $94.20.

PBH has been the subject of a number of analyst reports. DA Davidson lifted their price objective on shares of Prestige Consumer Healthcare from $93.00 to $95.00 and gave the company a “buy” rating in a report on Wednesday, August 28th. Jefferies Financial Group restated a “hold” rating and set a $76.00 price target (up from $70.00) on shares of Prestige Consumer Healthcare in a report on Tuesday, September 24th.

Hedge Funds Weigh In On Prestige Consumer Healthcare

Several hedge funds have recently bought and sold shares of PBH. Opal Wealth Advisors LLC purchased a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $26,000. Quest Partners LLC grew its stake in Prestige Consumer Healthcare by 2,826.7% in the 2nd quarter. Quest Partners LLC now owns 439 shares of the company’s stock worth $30,000 after buying an additional 424 shares in the last quarter. EverSource Wealth Advisors LLC grew its stake in Prestige Consumer Healthcare by 80.6% in the 1st quarter. EverSource Wealth Advisors LLC now owns 466 shares of the company’s stock worth $33,000 after buying an additional 208 shares in the last quarter. Gladius Capital Management LP purchased a new position in Prestige Consumer Healthcare in the 2nd quarter worth approximately $35,000. Finally, Northwestern Mutual Wealth Management Co. boosted its stake in shares of Prestige Consumer Healthcare by 562.3% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 510 shares of the company’s stock valued at $35,000 after purchasing an additional 433 shares in the last quarter. Hedge funds and other institutional investors own 99.95% of the company’s stock.

Prestige Consumer Healthcare Price Performance

Shares of NYSE PBH opened at $72.30 on Friday. Prestige Consumer Healthcare has a twelve month low of $56.61 and a twelve month high of $75.80. The firm has a fifty day simple moving average of $71.22 and a 200 day simple moving average of $69.28. The company has a market capitalization of $3.59 billion, a PE ratio of 17.34, a P/E/G ratio of 1.93 and a beta of 0.47. The company has a quick ratio of 1.90, a current ratio of 3.23 and a debt-to-equity ratio of 0.65.

Prestige Consumer Healthcare (NYSE:PBH) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.90 EPS for the quarter, topping analysts’ consensus estimates of $0.86 by $0.04. The business had revenue of $267.10 million during the quarter, compared to analysts’ expectations of $260.54 million. Prestige Consumer Healthcare had a net margin of 18.43% and a return on equity of 12.55%. The business’s quarterly revenue was down 4.4% on a year-over-year basis. During the same period last year, the company posted $1.06 earnings per share. On average, sell-side analysts forecast that Prestige Consumer Healthcare will post 4.43 EPS for the current year.

About Prestige Consumer Healthcare

Prestige Consumer Healthcare Inc, together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare.